laxogenin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 10950057 |
| SCHEMBL ID | 4027062 |
| MeSH ID | M0366359 |
| Synonym |
|---|
| laxogenin |
| SCHEMBL4027062 |
| 6-oxotigogenin |
| unii-ht7w184yg4 |
| ht7w184yg4 , |
| spirostan-6-one, 3-hydroxy-, (3.beta.,5.alpha.,25r)- |
| laxogenine |
| (25r)-3.beta.-hydroxy-5.alpha.-spirostan-6-one |
| (25r)-3beta-hydroxy-5alpha-spirostan-6-one |
| (2as,4s,5'r,6ar,6bs,8as,8br,9s,10r,11as,12as,12br)-4-hydroxy-5',6a,8a,9-tetramethylicosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-2(1h)-one |
| Q27280083 |
| (1r,2s,4s,5'r,6r,7s,8r,9s,12s,13r,16s,18s)-16-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-one |
| AKOS040752452 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||